Practice Tips

Hand in hand, on the path to change
B.C. government and BCPhA announce drug-pricing agreement

B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy.
New pediatric indication for Reyataz

Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age.
Stelara approved for psoriasis

Canada is the first country worldwide to approve Janssen-Ortho's Stelara for the treatment of psoriasis.
Survey: Side-effects a serious issue for CML patients

Many CML patients today are living with side effects so strong that their quality of life is greatly reduced, according to a survey by the CML Society of Canada.
Volibris for pulmonary arterial hypertension

GlaxoSmithKline's Volibris is a new endothelin receptor antagonist for the treatment of idiopathic (primary) pulmonary arterial hypertension, as well as PAH associated with connective tissue disease.
C-reactive protein test may help cut prescriptions for antibiotics

In-office blood test aims to direct care in respiratory tract infections
Think you’re superior to an IMG? Think again

LETTER: Need more dissidents to keep establishment on toes